Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.40 SEK | -2.07% | 0.00% | -20.67% |
08-29 | First Patient Dosed in Guard Therapeutics' Phase 2B Study POINTER | CI |
08-27 | Guard Therapeutics Plans New SEK80 Million Rights Issue to Fund Kidney Drug Study | MT |
MarketScreener is also available in this country: United States.
Switch edition